“…16 The distribution of the disease typically involves the mid and distal renal arteries and branchpoints and poses treatment challenges that separate FMD from atherosclerotic disease. 17 The development of smaller balloon dilation systems offers safe and highly effective treatment options for technically difficult lesions. Newer technology, such as cutting balloons, add to the armamentarium for treatment of resistant lesions, particularly in the setting of intimal fibrodysplasia.…”